182 related articles for article (PubMed ID: 26322631)
21. Structure-based design of submicromolar, biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase.
Aronov AM; Suresh S; Buckner FS; Van Voorhis WC; Verlinde CL; Opperdoes FR; Hol WG; Gelb MH
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4273-8. PubMed ID: 10200252
[TBL] [Abstract][Full Text] [Related]
22. Sugar derivatives as new 6-phosphogluconate dehydrogenase inhibitors selective for the parasite Trypanosoma brucei.
Pasti C; Rinaldi E; Cervellati C; Dallocchio F; Hardré R; Salmon L; Hanau S
Bioorg Med Chem; 2003 Apr; 11(7):1207-14. PubMed ID: 12628648
[TBL] [Abstract][Full Text] [Related]
23. Computer-aided discovery of Trypanosoma brucei RNA-editing terminal uridylyl transferase 2 inhibitors.
Demir O; Labaied M; Merritt C; Stuart K; Amaro RE
Chem Biol Drug Des; 2014 Aug; 84(2):131-9. PubMed ID: 24903413
[TBL] [Abstract][Full Text] [Related]
24. Anti-trypanosomal activity of doubly modified salinomycin derivatives.
Antoszczak M; Steverding D; Sulik M; Janczak J; Huczyński A
Eur J Med Chem; 2019 Jul; 173():90-98. PubMed ID: 30986574
[TBL] [Abstract][Full Text] [Related]
25. Benzimidazole inhibitors of the major cysteine protease of
Pereira GA; Santos LH; Wang SC; Martins LC; Villela FS; Liao W; Dessoy MA; Dias LC; Andricopulo AD; Costa MA; Nagem RA; Caffrey CR; Liedl KR; Caffarena ER; Ferreira RS
Future Med Chem; 2019 Jul; 11(13):1537-1551. PubMed ID: 31469332
[No Abstract] [Full Text] [Related]
26. Discovery of a novel class of orally active trypanocidal N-myristoyltransferase inhibitors.
Brand S; Cleghorn LA; McElroy SP; Robinson DA; Smith VC; Hallyburton I; Harrison JR; Norcross NR; Spinks D; Bayliss T; Norval S; Stojanovski L; Torrie LS; Frearson JA; Brenk R; Fairlamb AH; Ferguson MA; Read KD; Wyatt PG; Gilbert IH
J Med Chem; 2012 Jan; 55(1):140-52. PubMed ID: 22148754
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and biological evaluation of novel 4-alkapolyenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents--part III.
Ronga L; Del Favero M; Cohen A; Soum C; Le Pape P; Savrimoutou S; Pinaud N; Mullié C; Daulouede S; Vincendeau P; Farvacques N; Agnamey P; Pagniez F; Hutter S; Azas N; Sonnet P; Guillon J
Eur J Med Chem; 2014 Jun; 81():378-93. PubMed ID: 24858543
[TBL] [Abstract][Full Text] [Related]
28. Discovery of Indoline-2-carboxamide Derivatives as a New Class of Brain-Penetrant Inhibitors of Trypanosoma brucei.
Cleghorn LA; Albrecht S; Stojanovski L; Simeons FR; Norval S; Kime R; Collie IT; De Rycker M; Campbell L; Hallyburton I; Frearson JA; Wyatt PG; Read KD; Gilbert IH
J Med Chem; 2015 Oct; 58(19):7695-706. PubMed ID: 26418485
[TBL] [Abstract][Full Text] [Related]
29. Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design.
Bressi JC; Verlinde CL; Aronov AM; Shaw ML; Shin SS; Nguyen LN; Suresh S; Buckner FS; Van Voorhis WC; Kuntz ID; Hol WG; Gelb MH
J Med Chem; 2001 Jun; 44(13):2080-93. PubMed ID: 11405646
[TBL] [Abstract][Full Text] [Related]
30. Activity of Aromathecins against African Trypanosomes.
Nenortas NP; Cinelli MA; Morrell AE; Cushman M; Shapiro TA
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104277
[TBL] [Abstract][Full Text] [Related]
31. African trypanosomiasis: Synthesis & SAR enabling novel drug discovery of ubiquinol mimics for trypanosome alternative oxidase.
West RA; O'Doherty OG; Askwith T; Atack J; Beswick P; Laverick J; Paradowski M; Pennicott LE; Rao SPS; Williams G; Ward SE
Eur J Med Chem; 2017 Dec; 141():676-689. PubMed ID: 29107420
[TBL] [Abstract][Full Text] [Related]
32. Screening of acyl hydrazide proteinase inhibitors for antiparasitic activity against Trypanosoma brucei.
Caffrey CR; Schanz M; Nkemngu NJ; Brush M; Hansell E; Cohen FE; Flaherty TM; McKerrow JH; Steverding D
Int J Antimicrob Agents; 2002 Mar; 19(3):227-31. PubMed ID: 11932146
[TBL] [Abstract][Full Text] [Related]
33. Identification of novel inhibitors of UDP-Glc 4'-epimerase, a validated drug target for african sleeping sickness.
Urbaniak MD; Tabudravu JN; Msaki A; Matera KM; Brenk R; Jaspars M; Ferguson MA
Bioorg Med Chem Lett; 2006 Nov; 16(22):5744-7. PubMed ID: 16962325
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of analogs of 5'-(((Z)-4-amino-2-butenyl)methylamino)-5'-deoxyadenosine (MDL 73811, or AbeAdo) - An inhibitor of S-adenosylmethionine decarboxylase with antitrypanosomal activity.
Brockway AJ; Volkov OA; Cosner CC; MacMillan KS; Wring SA; Richardson TE; Peel M; Phillips MA; De Brabander JK
Bioorg Med Chem; 2017 Oct; 25(20):5433-5440. PubMed ID: 28807574
[TBL] [Abstract][Full Text] [Related]
35. Parasite-based screening and proteome profiling reveal orlistat, an FDA-approved drug, as a potential anti Trypanosoma brucei agent.
Yang PY; Wang M; Liu K; Ngai MH; Sheriff O; Lear MJ; Sze SK; He CY; Yao SQ
Chemistry; 2012 Jul; 18(27):8403-13. PubMed ID: 22674877
[TBL] [Abstract][Full Text] [Related]
36. Discovery of N-(4-sulfamoylphenyl)thioureas as Trypanosoma brucei leucyl-tRNA synthetase inhibitors.
Zhang F; Du J; Wang Q; Hu Q; Zhang J; Ding D; Zhao Y; Yang F; Wang E; Zhou H
Org Biomol Chem; 2013 Aug; 11(32):5310-24. PubMed ID: 23842857
[TBL] [Abstract][Full Text] [Related]
37. High-resolution crystal structure of Trypanosoma brucei pteridine reductase 1 in complex with an innovative tricyclic-based inhibitor.
Landi G; Linciano P; Tassone G; Costi MP; Mangani S; Pozzi C
Acta Crystallogr D Struct Biol; 2020 Jun; 76(Pt 6):558-564. PubMed ID: 32496217
[TBL] [Abstract][Full Text] [Related]
38. Inhibitors of human histone deacetylase with potent activity against the African trypanosome Trypanosoma brucei.
Kelly JM; Taylor MC; Horn D; Loza E; Kalvinsh I; Björkling F
Bioorg Med Chem Lett; 2012 Mar; 22(5):1886-90. PubMed ID: 22326398
[TBL] [Abstract][Full Text] [Related]
39. Crassiflorone derivatives that inhibit Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase (TbGAPDH) and Trypanosoma cruzi trypanothione reductase (TcTR) and display trypanocidal activity.
Uliassi E; Fiorani G; Krauth-Siegel RL; Bergamini C; Fato R; Bianchini G; Carlos Menéndez J; Molina MT; López-Montero E; Falchi F; Cavalli A; Gul S; Kuzikov M; Ellinger B; Witt G; Moraes CB; Freitas-Junior LH; Borsari C; Costi MP; Bolognesi ML
Eur J Med Chem; 2017 Dec; 141():138-148. PubMed ID: 29031061
[TBL] [Abstract][Full Text] [Related]
40. From Cells to Mice to Target: Characterization of NEU-1053 (SB-443342) and Its Analogues for Treatment of Human African Trypanosomiasis.
Devine WG; Diaz-Gonzalez R; Ceballos-Perez G; Rojas D; Satoh T; Tear W; Ranade RM; Barros-Álvarez X; Hol WG; Buckner FS; Navarro M; Pollastri MP
ACS Infect Dis; 2017 Mar; 3(3):225-236. PubMed ID: 28110521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
